BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 36760117)

  • 1. Ocular complications of plasma cell dyscrasias.
    Singh RB; Singhal S; Sinha S; Cho J; Nguyen AX; Dhingra LS; Kaur S; Sharma V; Agarwal A
    Eur J Ophthalmol; 2023 Sep; 33(5):1786-1800. PubMed ID: 36760117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular disorders associated with paraproteinemia.
    Hoffman-Snyder C; Smith BE
    Phys Med Rehabil Clin N Am; 2008 Feb; 19(1):61-79, vi. PubMed ID: 18194750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic manifestations of monoclonal gammopathy.
    Decaux O; Laurat E; Perlat A; Cazalets C; Jego P; Grosbois B
    Eur J Intern Med; 2009 Sep; 20(5):457-61. PubMed ID: 19712843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of peripheral neuropathy in plasma cell disorders.
    Silberman J; Lonial S
    Hematol Oncol; 2008 Jun; 26(2):55-65. PubMed ID: 18324611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurologic aspects of plasma cell disorders.
    Sobol U; Stiff P
    Handb Clin Neurol; 2014; 120():1083-99. PubMed ID: 24365373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma cell dyscrasias: current status.
    Kyle RA; Greipp PA
    Crit Rev Oncol Hematol; 1988; 8(2):93-152. PubMed ID: 3046767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment.
    Rajkumar SV; Dispenzieri A; Kyle RA
    Mayo Clin Proc; 2006 May; 81(5):693-703. PubMed ID: 16706268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dysglobulinemic neuropathies].
    Gherardi R; Zuber M; Viard JP
    Rev Neurol (Paris); 1988; 144(6-7):391-408. PubMed ID: 2847276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dealing with neuropathy in plasma-cell dyscrasias.
    Sonneveld P; Jongen JL
    Hematology Am Soc Hematol Educ Program; 2010; 2010():423-30. PubMed ID: 21239830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When a Monoclonal Gammopathy Is Not Multiple Myeloma.
    Derman B; Castillo JJ; Sarosiek S; Beksac M
    Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-10. PubMed ID: 35394823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of monoclonal gammopathies.
    Alexanian R; Weber D; Liu F
    Arch Pathol Lab Med; 1999 Feb; 123(2):108-13. PubMed ID: 10050782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurologic manifestations of monoclonal gammapathies].
    Uldry PA; Steck AJ; Regli F
    Schweiz Med Wochenschr; 1984 Nov; 114(47):1678-85. PubMed ID: 6096963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
    Khouri J; Nakashima M; Wong S
    JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living with Polyneuropathy Organomegaly Endocrinopathy Monoclonal gammopathy Skin changes (POEMS) syndrome: a case study of healthcare experiences and quality of life.
    Twigg J; Methley A; Lavin T; Dickinson G; Teager A
    Disabil Rehabil; 2021 Aug; 43(17):2502-2510. PubMed ID: 31838877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular manifestations of multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy.
    Orellana J; Friedman AH
    Surv Ophthalmol; 1981; 26(3):157-69. PubMed ID: 6801795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Gammopathies of 'Neurological Significance': Paraproteinemic Neuropathies.
    Mani AM; Devasia AJ; Nair A; Benjamin RN; Prabhakar AT; Sivadasan A; Mathew V; Aaron S; George B; Alexander M
    Can J Neurol Sci; 2021 Sep; 48(5):616-625. PubMed ID: 33397535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of neuropathies associated with plasma cell dyscrasias.
    Rosenbaum E; Marks D; Raza S
    Hematol Oncol; 2018 Feb; 36(1):3-14. PubMed ID: 28397326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal gammopathy of ocular significance (MGOS) - a short survey of corneal manifestations and treatment outcomes.
    Garderet L; Al Hariri M; Wasielica-Poslednik J; Munder M; Kormányos K; Pena C; Gozzetti A; Zhou X; Waszczuk-Gajda A; Rosinol L; Mikala G; Krzystanski M; Lisch W; Vesole D; Szentmáry N; Jurczyszyn A
    Leuk Lymphoma; 2022 Apr; 63(4):984-990. PubMed ID: 34823428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological profile of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome.
    Kulkarni GB; Mahadevan A; Taly AB; Yasha TC; Seshagiri KS; Nalini A; Satishchandra P; Veerendrakumar M; Shankar SK
    J Clin Neurosci; 2011 Mar; 18(3):356-60. PubMed ID: 21256753
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.